EPA deals five-month delay to Tristel

Infection prevention, contamination control and hygiene products manufacturer Tristel announced a change to the expected approval date from the United States Environmental Protection Agency (EPA) for its foam-based chlorine dioxide product ‘Duo’ on Tuesday.

The AIM-traded firm had met with the EPA in October 2016, with subsequent communications with the agency guiding the scope and content of the company's Duo submission which was made on 30 June.

It said the EPA had now informed the company that it changed its approach, and additional information had now been requested.

Tristel said that additional data had largely been compiled and submitted, and as a result, the EPA approval was now expected in May 2018, rather than late 2017 as it originally anticipated.

Approval would be followed by the state-by-state registration process, and the company's revenue expectations were not affected by what the board called a “slight” delay.

“Whilst we are disappointed that the EPA's change of approach will require us to restart the submission timetable and incur a five-month delay to the timetable that we originally anticipated, our expectation for first revenues from North America in financial year 2018-19 remains unchanged,” said Tristel CEO Paul Swinney.